Marcaine Injection, Solution
Product Images NDC 0404-9770

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Marcaine (NDC 0404-9770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of bupivacaine hydrochloride, showing the molecular arrangement including a piperidine ring, an amide linkage, aromatic ring with two methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram showing the molecular structure of bupivacaine hydrochloride, the active ingredient in Marcaine 2.5 mg/mL injection solution by Henry Schein, Inc.*

FDA Label Image

Image1.jpg (Image1)

A table titled 'Types of Block and Recommended MARCAINE / MARCAINE WITH EPINEPHRINE Concentrations' showing various types of nerve blocks and the indicated concentrations of Marcaine and Marcaine with Epinephrine for each block. Concentrations listed include 0.25% (2.5 mg/mL), 0.5% (5 mg/mL), and 0.75% (7.5 mg/mL) for Marcaine, and 0.25% and 0.5% for Marcaine with Epinephrine. It notes specific clinical considerations and recommended uses for each concentration and block type.*

FDA Label Image

Image2.jpg (Image2)

A table titled "MARCAINE / MARCAINE WITH EPINEPHRINE Concentration vs. Motor Function" comparing motor function effects at different Marcaine (bupivacaine hydrochloride) concentrations. Concentrations listed are 0.25% (2.5 mg/mL), 0.5% (5 mg/mL), and 0.75% (7.5 mg/mL), with detailed descriptions of the degree of motor block and clinical considerations for each concentration.*

FDA Label Image

Image3.jpg (Image3)

A data table presenting recommended concentrations and doses of Marcaine injection (bupivacaine hydrochloride) with or without epinephrine for adults. It lists different types of nerve blocks—local infiltration, peripheral nerve block, and retrobulbar block—showing corresponding concentrations, dose volumes, milligrams of Marcaine per dose, and the extent of motor block expected.*

FDA Label Image

Image4.jpg (Image4)

A dosage table showing various blocks and test doses for bupivacaine hydrochloride injection. It includes concentrations in mg/mL, dose ranges, and degrees of block completion for sympathetic, caudal, lumbar epidural, epidural test dose, and dental blocks, with notes on usage and epinephrine inclusion.*

FDA Label Image

Image5.jpg (Image5)

A table titled 'Examples of Drugs Associated with Methemoglobinemia,' listing drug classes including Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with example drugs named for each class. Local anesthetics include bupivacaine.*

FDA Label Image

Image6.jpg (Image6)

A data table listing various units of sale and concentrations for bupivacaine hydrochloride injection, solution under different NDC codes. The table details trays and cartons of single-dose and multiple-dose vials with concentrations of 0.25% (2.5 mg/mL) and 0.5% (5 mg/mL), including vial counts and corresponding total milligrams per vial volume.*

FDA Label Image

Image7.jpg (Image7)

A table presenting various packaging configurations of a drug with different NDC codes, strengths (0.5% and 0.75%), vial types (single-dose and multiple-dose), vial counts per carton or tray, and corresponding quantities in mg per mL or per total volume.*

FDA Label Image

Image8.jpg (Image8)

Data table listing various unit of sale options and concentrations for Marcaine (bupivacaine hydrochloride) injection, solution. It details NDC codes, packaging formats (single-dose or multiple-dose vials, with carton sizes), and corresponding strengths (0.25% and 0.5%) with amounts in mg and mL, including concentration in mg/mL.*

FDA Label Image

Label1.jpg (Label1)

Label for Marcaine 0.25% (bupivacaine hydrochloride) injection, solution at 2.5 mg/mL strength in a 10 mL single-dose vial. Indicated for infiltration, nerve block, caudal, and epidural anesthesia; not for intrathecal use. Preservative-free and packaged by Henry Schein, Inc., Bastian, VA. Includes storage instructions and barcode with NDC 0404-9770-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.